Drug intelligence / Profile preview

Cyclo 3

Development stage
Unknown
Lead developer
Pierre Fabre
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical
01

Overview

Cyclo 3 (commonly marketed as Cyclo 3 Fort) is a well-established venotonic and vasculoprotective combination drug developed by Pierre Fabre. It consists of three active ingredients: a dry extract of butcher's broom (*Ruscus aculeatus*), hesperidin methyl chalcone, and ascorbic acid (Vitamin C). The combination is widely used for the symptomatic treatment of chronic venous insufficiency (including heavy legs, pain, and nocturnal cramps), hemorrhoidal crises, and certain types of gynecological bleeding (such as metrorrhagia associated with intrauterine devices or microprogestogen contraception). *Ruscus aculeatus* extract acts as an agonist of postsynaptic alpha-adrenergic receptors, promoting venoconstriction and improving venous tone. Hesperidin methyl chalcone, a flavonoid, reduces capillary permeability and increases capillary resistance, while ascorbic acid protects capillary walls and supports collagen synthesis.

Brand names
CiclotresCyclo 3 FortCyclo3 FortCyclo-3 Fort
Other names
Ruscogenina en asociaciónRuscus aculeatus extract + hesperidin methyl chalcone + ascorbic acid
02

Targets

ADRA1A (α1A)ADRA2A (α2A)

Beyond the preview

Go deeper on Cyclo 3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclo 3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call